Our Approach

The Concept

AnnularBio was developed when its Founders recognized the market demand for reliability in contract manufacturing of high quality monoclonal antibodies (mAbs). Through their collective experiences in the biotechnology industry, specifically  commercial R&D reagents, they observed the negative consequences that questionable mAbs have on institutional researchers.

Challenging the complacency of the commercial mAb market, they desired to provide innovative and intelligent solutions for researchers that require functional mAbs. Today, AnnularBio has not only developed a methodology for selecting high-value hybridomas but they have an accelerated success rate for Clients with their discovery process.

Philosophy

Identifying a reliable source for contract manufacturing of monoclonal antibodies (mAbs) drives successful research projects. The desirable properties of these molecules are critical for development of diagnostics and therapeutics. AnnularBio understands these requirements and provides rigorous consultation with prospective clients to understand their specific needs.

AnnularBio has developed a novel approach to mAb discovery with a foundation in combined technologies. This approach optimizes methods for selecting high-value hybridomas and unique mAbs. AnnularBio offers clients the ABitope Kit, or a panel of complimentary mAbs suitable for use in multiple platforms. This product gives our clients a competitive edge  when making difficult pre-clinical decisions. We strive to reduce your time and costs in R&D that translate into success entering the marketplace or clinic

Custom Monoclonal Antibodies

A custom monoclonal antibody solution is ideal when commercial options are limited and polyclonal antibodies are incompatible with future development. AnnularBio is dedicated to meeting the challenges and specific needs of our clients.

If you are interested in our products or services, please contact us to begin the consultation process.aims to accelerate glycobiology research and provide the next generation of reagents that enable new discoveries and clinical applications.

ABitope Kit

The technology that drives the ABitope Kit facilitates rapid discovery of unique and complementary monoclonal antibodies against its target. This results in diverse epitope binding and high affinity antibodies from stable cell lines. Our antigen display technologies and unique discovery platform isolates antibodies that access multiple epitopes, even among low mass and polymeric molecules.

If you are interested in the develpment of your custom ABitope Kit, please contact us.